A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib
Completed · Phase 1
Conditions studied: Healthy Adults
In brief
An Open-label, Randomized, Three-period, Crossover Study of the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects
Key facts
- Study ID
- NCT04800614
- Run by
- Mirati Therapeutics Inc.
- People needed
- 36
- Starts
- 2021-03-15
- Expected to finish
- 2022-03-28
- Last updated by the study team
- 2022-04-06
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Covance Clinical Research Unit, Inc. — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.